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Abstract: Background: A subgroup of patients recovering from COVID-19 experience persistent
symptoms, decreased quality of life, increased dependency on others for personal care and impaired
performance of activities of daily living. However, the long-term effects of COVID-19 on physical
activity (PA) in this subgroup of patients with persistent symptoms remain unclear. Methods: Demo-
graphics, self-reported average time spent walking per week, as well as participation in activities
pre-COVID-19 and after three and six months of follow-up were assessed in members of online
long-COVID-19 peer support groups. Results: Two hundred thirty-nine patients with a confirmed
COVID-19 diagnosis were included (83% women, median (IQR) age: 50 (39–56) years). Patients
reported a significantly decreased weekly walking time after three months of follow-up (three months:
60 (15–120) min. vs. pre-COVID-19: 120 (60–240) min./week; p < 0.05). Six months after the onset of
symptoms walking time was still significantly lower compared to pre-COVID-19 but significantly
increased compared to three months of follow-up (three months: 60 (15–120) min. vs. six months: 90
(30–150) min.; p < 0.05). Conclusions: Patients who experience persistent symptoms after COVID-19
may still demonstrate a significantly decreased walking time six months after the onset of symptoms.
More research is needed to investigate long-term consequences and possible treatment options to
guide patients during the recovery fromCOVID-19.
Keywords: Corona; exercise; persistent symptoms; physical activity
1. Introduction
At the time of writing, the number of people with a confirmed diagnosis of coronavirus
disease 2019 (COVID-19) has risen to 167 million globally, with over 1.6 million confirmed
cases in the Netherlands and over 1 million cases in Belgium [1]. As the pandemic continues,
many patients have passed through the acute phase of the disease, but may still face
difficulties in resuming their daily routine.
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It has already been demonstrated that hospitalized patients with COVID-19 present
with low physical functioning and impaired performance in activities of daily living (ADLs)
immediately after discharge [2]. Several months after the infection, a subgroup of patients
with COVID-19 still report ongoing symptoms such as fatigue, dyspnoea and muscle
weakness, as well as impaired quality of life and increased dependency on others for
personal care and the performance of ADLs [3–11]. This suggests the presence of a post-
COVID-19 syndrome [4,12,13], which was recently referred to as post-acute sequelae of
SARS-CoV-2 infection (PASC) by the National Institutes of Health (NIH) [14]. Moreover, a
qualitative study indicated that the experience of prolonged symptoms hampers patients
in resuming or maintaining physical activity [15]. Similar to other countries, the Dutch
and Belgian governments decided to close sport clubs and requested residents’ home
confinement as a measure to limit the rate of infections (Netherlands closed sport clubs
on 15 March 2020 and requested home confinement on 23 March 2020; Belgium closed
sport clubs and requested home confinement on 13 March 2020) [16,17]. Previous studies
have already demonstrated that those governmental measures led to a decrease in physical
activity (PA) among other unhealthy lifestyle behaviours in the general population [18,19].
However, the long-term effects in patients with COVID-19 on PA levels remain unclear.
Therefore, the aim of this study was to assess the impact of COVID-19 on the level
of self-reported PA (time spent walking per week and leisure-time sports activities) in
patients with post-COVID-19 syndrome (i.e., long COVID, long-haul COVID or PASC). We
hypothesized a significant decrease in PA approximately three months after the infection,
and at least a partial recovery of PA six months after the infection.
2. Materials and Methods
2.1. Study Design and Participants
As part of a large longitudinal study conducted in the Netherlands and Flanders
(Belgium), an online questionnaire was made available between June 4 and June 11 of 2020
(T1) to all members of two long COVID Facebook groups [20,21] and to an online COVID-
19 panel (www.coronalongplein.nl) (accessed on 4 June 2020). In total, 1556 participants
who agreed to take part in a follow-up of this study were asked to complete a second
survey between August 31 and September 8 of 2020 (T2). The medical ethics committee
of the Maastricht University stated that the Medical Research Involving Human Subjects
Act (WMO) did not apply to this study and that an official approval of this study by
the committee was not required (METC2020-1978, METC2020-2554). The medical ethics
committee of Hasselt University formally judged and approved the study (MEC2020/041).
All adult respondents (aged 18 years or older) gave digital informed consent at the start of
the questionnaires. Data about symptoms, care dependency, information needs, functional
status, work productivity and quality of life have been published before [4,22–26].
2.2. Outcome Measures
The survey contained questions regarding demographics (sex (male/female/other),
age (years), body mass index (BMI) (kg/m2), marital status (married or living with partner:
yes/no), education level (low/medium/high)), self-reported pre-existing comorbidities,
COVID-19 diagnosis (based on reverse transcription polymerase chain reaction (RT-PCR)
test and/or computed tomography (CT) scan of the thorax; symptom-based medical diagno-
sis; no test/medical diagnosis), received care (no care needed/physiotherapy/rehabilitation),
symptoms and admission to hospital.
In addition, participants were asked about the average time they spent walking in
the previous seven days and which sports/activities they performed before COVID-19
(retrospectively) and at the time of completing the two questionnaires (approximately three
and six months after symptom onset, respectively) (A summary of the questionnaire is
added in the online supplement). The World Health Organization (WHO) recommends
a minimum of 150 min per week of moderate-intensity aerobic physical activity [27].
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Therefore, participants were divided into two groups: average walking time of less than
150 min per week or an average walking time of 150 min or more per week.
2.3. Statistical Analysis
Initial analyses were performed in participants with an RT-PCR or CT-confirmed
diagnosis. Participants with a presumed COVID-19 diagnosis (n = 766; data presented in
the online supplement) were excluded from the primary analyses.
Statistical analyses and visualizations were performed using SPSS v25.0 (IBM Corp.,
Armonk, NY, USA), SankeyMATIC (http://sankeymatic.com/build/) (accessed on 4 June
2020) and GraphPad Prism 8.3.5. (GraphPad Software, La Jolla, CA, USA). Data were
presented as mean and standard deviation (SD), median and interquartile range (IQR)
or frequency and proportion, as appropriate. Data were tested for normality with a
Kolmogorov–Smirnov test. Within-group comparisons were performed using the Friedman
test, McNemar’s test or standard Cochran’s Q test (with Bonferroni corrected post-hoc test).
Between-group comparisons were performed using a Mann–Whitney U test or Fisher’s
exact test. A priori, the level of significance was set at p < 0.05.
3. Results
3.1. Demographics and Characteristics
Of the initial 1556 participants that consented to be approached for a second question-
naire, 1005 participants completed the online questionnaires at approximately six months.
See Supplementary Figure S1 for all details. Data from 239 participants with an RT-PCR or
CT-confirmed diagnosis (82.8% women; median age: 50 (39–56) years) were used for the
primary analyses, of which 62 (26%) were hospitalized (but not admitted to the intensive
care unit (ICU)). The average time between the onset of symptoms and filling out the
questionnaires was 10.4 ± 2.4 weeks (T1) and 22.6 ± 2.4 weeks (T2).
All characteristics of the 239 participants with a confirmed COVID-19 diagnosis are
presented in Table 1. Results stratified for hospital admission are presented in the online
supplement (Supplementary Tables S2 and S3 and Supplementary Figure S3).
Table 1. General characteristics of participants.
All Participants (n = 239)
Hospitalized due to COVID-19, n (%) 62 (25.9)
Women, n (%) 198 (82.8)
Age, years, median (IQR) 50.0 (39.0–56.0)
Body mass index (BMI), kg/m2, median (IQR) 26.0 (23.4–30.5)
Marital status—married/living with partner, n (%) 173 (72.4)
Education level, n (%)
Low 6 (2.5)
Medium 126 (52.7)
High 107 (44.8)
Self-reported pre-existing comorbidities, n (%)
None 142 (59.4)
1 comorbidity 62 (25.9)
≥2 comorbidities 35 (14.6)
Received care
No care needed, %
Between infection and 3 months of follow-up 14.6
Between 3 and 6 months of follow-up 14.2
Physiotherapy, %
Between infection and 3 months of follow-up 31.8
Between 3 and 6 months of follow-up 61.9 #
Rehabilitation, %
Between infection and 3 months of follow-up 4.2
Between 3 and 6 months of follow-up 11.7 #
# p < 0.05 vs. 3 months of follow-up.
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3.2. Self-Reported Walking Time
Results regarding self-reported time spent walking per week at the three time points
(pre-COVID-19 (T0) and three (T1) and six months (T2) of follow-up) are presented in
Figure 1. After three months of follow-up, walking time in the previous week was sig-
nificantly reduced compared to pre-COVID-19 (three months: 60 (15–120) min. vs. pre-
COVID-19: 120 (60–240) min./week; p < 0.05). Although there was a recovery in walking
time between three months and six months of follow-up (from 60 (15–120) min. to 90 (30–
150) min.; p < 0.05), walking time was still significantly lower compared to pre-COVID-19.
Figure 1. Walking time in previous week pre-COVID-19 (T0), at 3 months (T1) and 6 months (T2) of
follow-up; * significant difference vs. pre-COVID-19, p < 0.05; #: significant difference vs. 3 months,
p < 0.05. Data presented as median, IQR and 10–90%CI.
The proportion of participants reporting walking ≥150 min. per week at the different
time points is presented in Figure 2. Approximately 41% of the participants reported
walking ≥150 min. per week before COVID-19. This was significantly lower after three
(17%) and six months (28%) of follow-up. Only 9% of participants reported walking
≥150 min. per week at all three time points. Approximately 20% of participants reported
walking ≥150 min. per week pre-COVID-19 but did not achieve this at three and six
months of follow-up, while 11% decreased their walking time per week (from ≥150 min.
to <150 min. per week) at three months of follow-up but restored it to ≥150 min. at
six months of follow-up. There were no significant differences in baseline characteristics
between participants walking ≥150 min. per week and participants walking <150 min. per
week, with the exception of the proportion of patients undergoing rehabilitation between
three and six months of follow-up (<150 min.: 8%; ≥150 min.: 17%; p = 0.04). Additional
analyses of walking time stratified for sex and number of symptoms are reported in the
online supplements (Supplementary Tables S4 and S5)
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3.3. Activities
Participants reported a wide variety of activities, with walking (pre-COVID-19: 53.1%;
three months: 41.1%; six months: 68.2%), outdoor cycling (pre-COVID-19: 35.1%; three
months: 21.3%; six months: 42.3%) and (physio)fitness/exercise groups (pre-COVID-19:
30.1%; three months: 10.0%; six months: 38.5%) as the three most reported activities
(Table 2).
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Table 2. Activities performed by participants before (T0) and at three (T1) and six months (T2) of follow-up.
Sport/Activity, n (%)
All Participants (n = 239)
T0 T1 T2
1 Walking 127(53.1) 99(41.1) * 163(68.2) *#
2 Cycling outdoors 84(35.1) 51(21.3) * 101(42.3) #
3 (Physio)fitness/exercise groups 72(30.1) 24(10.0) * 92(38.5) #
4 Swimming 24(10.0) 9(3.8) * 14(5.9) *
5 Running 24(10.0) 7(2.9) * 28(11.7) #
6 Yoga/Pilates 12(5.0) 0(0.0) * 7(2.9)
7 Racket sports 10(4.2) 1(1.3) * 4(1.7) *
8 Team sports 8(3.3) 0(0.0) * 2(0.8)
9
Martial arts 5(2.1) 1(0.4) 0(0.0) *
Cycling indoors 5(2.1) 10(4.2) 28(11.7) *#
Work-related activities 5(2.1) 0(0.0) * 0(0.0) *
10 Dancing 4(1.7) 0(0.0) * 0(0.0) *
No sports/activities, regardless of COVID-19 27(11.3) 9(3.8) * 5(2.1) *
No sports/activities, due to COVID-19 N.A. 104(43.5) 28(11.7) #
*: significant difference vs. pre-COVID-19, p < 0.05; #: significant difference vs. three months, p < 0.05.
At three months of follow-up, participants reported performing fewer activities com-
pared to pre-COVID-19 and almost 44% of the participants were not able to be physically
active or perform sports or activities due to COVID-19. From three months to six months
of follow-up the proportion of participants unable to be physically active significantly
decreased (from 44% to 12%; p < 0.05) and the proportion of participants reporting walking,
cycling outdoors/indoors, participating in (physio)fitness/exercise groups and running
significantly increased. The proportion of participants that reported walking and cycling
indoors at six months was significantly higher compared to pre-COVID-19.
4. Discussion
This study aimed to assess the impact of COVID-19 on the level of self-reported PA
(time spent walking per week and leisure-time sports activities) in patients with post-
COVID-19 syndrome (i.e., long COVID, long-haul COVID or PASC). As hypothesized, a
significant decrease in walking time approximately three months after the infection and a
partial recovery of walking time six months after the infection was found.
These results indicate a possible recovery pattern similar to that which has been
established in influenza A, acute respiratory distress syndrome survivors and severe acute
respiratory syndrome, where patients experience impaired health-related quality of life,
functional disability, psychological problems and impaired exercise capacity after up to
two years of follow-up [28–31].
Since the Dutch healthcare system was completely overwhelmed by the COVID-19
pandemic, the primary focus was the treatment of patients with the most life-threatening
symptoms. People without the need for ICU admission, were understandably not pri-
oritized during these hectic times, and therefore not intensively monitored or guided in
their recovery. Complications like myocarditis or thromboembolic problems might have
been missed and therefore might have hindered the recovery of PA in this subgroup of
patients [32,33].
Furthermore, since the effects of COVID-19 on the human body are still not completely
clear, it is important to consider that patients might recover along different trajectories.
Indeed, Gandotra et al. have investigated recovery in patients with respiratory failure
Int. J. Environ. Res. Public Health 2021, 18, 6017 7 of 11
due to several causes and identified different recovery trajectories and characteristics [34].
It is feasible that similar trajectories are present in patients recovering from COVID-19.
Additionally, a study by Sallis et al. has shown that the level of PA pre-COVID-19 is
associated with the severity of COVID-19. In fact, physical inactivity was the strongest risk
factor for hospital admission, ICU admission and death, exceeding well-known risk factors
like smoking, obesity, diabetes, hypertension, cardiovascular disease and cancer [35]. Since
PA pre-COVID-19 seems to have a large impact on three important outcomes after COVID-
19 (hospital admission, ICU admission and death), we recommend further investigation of
the association between PA and outcomes after COVID-19 in a population of patients with
persistent symptoms.
Although encouraging patients to return to performing daily activities and to start
low/moderate-intensity exercise at home is currently recommended for patients recovering
from COVID-19 [36,37], Humphreys et al. have described that patients experienced a lack
of clear and consistent advice with regard to PA and refraining from PA after suffering
a relapse in symptoms after PA or after seeing others relapse after PA [15]. In patients
with persistent symptoms, it is recommended to perform a post-COVID-19 assessment and
referring them to specialists or pulmonary rehabilitation based on the clinical findings [3].
A patient-tailored approach is needed in order to achieve an optimal recovery after an
infection with COVID-19 [15].
While interpreting the abovementioned results, some strengths and limitations of this
study need to be considered.
One of the strengths of this study is the fact that this is the first longitudinal study
investigating PA in patients with post-COVID-19 syndrome. We were able to follow up
with a significant number of participants during the course of six months. A team of
scientists, methodologists and patients worked together during the preparation of this
study in order to create a study that provided a complete overview of relevant parameters
in this specific population.
However, since participants were recruited through platforms that targeted patients
with persistent symptoms, there is the possibility of selection bias and the external validity
of these results might be limited. It is possible that participants that recovered after three
months did not feel the need to fill in the questionnaire at six months and therefore are
underrepresented. However, the additional analyses demonstrate that non-responders had
a significantly lower walking time three months after the onset of symptoms, compared to
the responders (median (IQR) 40 (10–95) vs. 59 (15–105) min. respectively; p = 0.046) while
walking time before COVID-19 was similar. This indicates that non-responders showed
even less recovery of PA compared to responders.
Additionally, females are overrepresented in this sample, possibly due to the higher
proportion of women that are part of online long COVID support groups [38]. This is
consistent with the gender distribution in previous studies [8,38–40]. Additional analyses
on walking times stratified for gender demonstrated that female participants had a sig-
nificantly lower walking duration compared to males at T1 and T2, while no differences
were found at T0. This could indicate that the recovery of walking time differs between
males and females. Taking the previously mentioned limitations into consideration, there
are limitations in extrapolating these results to the general population.
Due to the national regulations that were in place during the first wave of COVID-19
infections, the possibilities for sports and activity were limited. In both the Netherlands
and Belgium, a lockdown was proclaimed, people were asked to stay at home as much
as possible and sport facilities were closed. Therefore, the decrease in activities that were
not possible during a large part of the three months after symptom onset (e.g., swimming,
team sports) is probably caused by the regulations that were in place at that time. However,
at the same time, many sports clubs initiated alternative options like online dance and
exercise classes to provide the possibility to exercise at home or outdoors. The regulations
that were in place at the time also do not explain the difference in walking time. However,
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the increase in the proportion of participants who reported walking as an activity might be
related to the regulation.
Since the pandemic had a huge impact on healthcare resources, medical treatments
were focused on the most severe cases of COVID-19 and patients with “milder” symptoms
were often not tested. As a result, many patients who presented with milder symptoms
were not admitted to the hospital or even officially diagnosed with COVID-19 and remained
under the medical radar. The NICE guidelines have indicated that having a positive RT-
PCR test or hospitalization is not a requirement for a COVID-19 diagnosis and healthcare
should also focus on patients with suspected COVID-19 [13]. In line with these guidelines,
we believe that the group of study participants with presumed COVID-19 provides valuable
information and needs further attention. Results of participants with presumed COVID-19
are mostly comparable with the results of the participants with a confirmed diagnosis,
and are presented in the online supplement (Supplementary Table S1 and Supplementary
Figures S2 and S3).
Participants were asked to retrospectively assess their physical activity by filling in
questionnaires. Therefore, the effect of recall bias cannot be excluded. However, since
participants were asked questions that referred to the previous three months or the previous
seven days, we expect that the influence of recall bias is limited. Besides recall bias
in general, Dyrstad et al. have shown that a self-reported assessment of PA tends to
overestimate vigorous activity and underestimate sedentary time [41]. This effect might
have led to an overestimation of walking time in our results. Additionally, the questionnaire
on sports and activities other than walking provided no information on frequency, intensity
or duration, but only whether or not the activity was performed. This limitation should
be kept in mind when interpreting these results. At the time of inclusion, due to the acute
outbreak of COVID-19, it was impossible to provide participants with accelerometers
and perform an objective pre-and post-COVID-19 PA assessment, but in future research
objectively measured PA could be used to gain a more complete picture of the PA level in
this population.
5. Conclusions
Participants with persistent symptoms while recovering from COVID-19 who were
all members of online long COVID support groups still demonstrated a significantly
decreased self-reported walking time six months after the onset of symptoms. In contrast,
the proportion of participants that reported walking or cycling indoors increased over the
course of six months after the onset of symptoms. More research is needed to investigate
the long-term consequences and possible treatment options to guide patients during the
recovery from COVID-19.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/ijerph18116017/s1. Figure S1: Flowchart of included and excluded participants; Figure
S2: Walking time in previous week pre-COVID-19 (T0), at three months of follow-up (T1) and six
months (T2) of follow-up of participants with suspected COVID-19; Figure S3: Walking time in
previous week pre-COVID-19 (T0), at three months (T1) and six months (T2) of follow-up after
stratification into hospitalized and non-hospitalized; Table S1: General characteristics of participants
with suspected COVID-19; Table S2: General characteristics of participants stratified into hospitalized
and non-hospitalized; Table S3: Activities performed by participants before (T0) and three (T1) and
six months (T2) of follow-up stratified into hospitalized and non-hospitalized; Table S4: Walking
duration stratified for sex; Table S5: Walking duration stratified for number of symptoms.
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